211 related articles for article (PubMed ID: 36002805)
21. [Exploratory study on detection of drug resistance of
Liu YY; Shi J; Chu P; Wu TY; Li L; Pang Y; Lu J; Guo YL
Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jun; 45(6):552-559. PubMed ID: 35658379
[No Abstract] [Full Text] [Related]
22. Whole Genome Sequencing of Mycobacterium tuberculosis under routine conditions in a high-burden area of multidrug-resistant tuberculosis in Peru.
Puyén ZM; Santos-Lázaro D; Vigo AN; Cotrina VV; Ruiz-Nizama N; Alarcón MJ; Asto B; Huamán T; Moore DAJ
PLoS One; 2024; 19(6):e0304130. PubMed ID: 38861531
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].
Şimşek H; Tarhan G; Cesur S
Mikrobiyol Bul; 2015 Jan; 49(1):47-55. PubMed ID: 25706730
[TBL] [Abstract][Full Text] [Related]
24. [Study on the resistance of rifampicin-resistant Mycobacterium tuberculosis to anti-tuberculosis drugs in group A].
Dai XW; Li CY; Wang NH; Chen SS; Tian LL; Zhao YF; Tao LY; Yang XY; Ding BC; He XX
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Nov; 46(11):1110-1117. PubMed ID: 37914422
[No Abstract] [Full Text] [Related]
25. Epidemiological cut-offs for Sensititre susceptibility testing of Mycobacterium tuberculosis: interpretive criteria cross validated with whole genome sequencing.
Ismail NA; Ismail F; Joseph L; Govender N; Blows L; Kaniga K; Omar SV
Sci Rep; 2020 Jan; 10(1):1013. PubMed ID: 31974497
[TBL] [Abstract][Full Text] [Related]
26. MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs.
Heifets L
Antimicrob Agents Chemother; 1988 Aug; 32(8):1131-6. PubMed ID: 2461162
[TBL] [Abstract][Full Text] [Related]
27. Accuracy of whole genome sequencing versus phenotypic (MGIT) and commercial molecular tests for detection of drug-resistant Mycobacterium tuberculosis isolated from patients in Brazil and Mozambique.
Feliciano CS; Namburete EI; Rodrigues Plaça J; Peronni K; Dippenaar A; Warren RM; Silva WA; Bollela VR
Tuberculosis (Edinb); 2018 May; 110():59-67. PubMed ID: 29779775
[TBL] [Abstract][Full Text] [Related]
28. Validation of a novel medium for drug susceptibility testing of
Coban AY
Int J Mycobacteriol; 2021; 10(1):19-25. PubMed ID: 33707367
[TBL] [Abstract][Full Text] [Related]
29. Assessment of a 96-Well Plate Assay of Quantitative Drug Susceptibility Testing for Mycobacterium Tuberculosis Complex in China.
Xia H; Zheng Y; Zhao B; van den Hof S; Cobelens F; Zhao Y
PLoS One; 2017; 12(1):e0169413. PubMed ID: 28081169
[TBL] [Abstract][Full Text] [Related]
30. Minimum inhibitory concentrations of rifampin and isoniazid among multidrug and isoniazid resistant Mycobacterium tuberculosis in Ethiopia.
Getahun M; Blumberg HM; Ameni G; Beyene D; Kempker RR
PLoS One; 2022; 17(9):e0274426. PubMed ID: 36099255
[TBL] [Abstract][Full Text] [Related]
31. Multicentre testing of the EUCAST broth microdilution reference method for MIC determination on Mycobacterium tuberculosis.
Schön T; Werngren J; Machado D; Borroni E; Wijkander M; Lina G; Mouton J; Matuschek E; Kahlmeter G; Giske C; Santin M; Cirillo DM; Viveiros M; Cambau E
Clin Microbiol Infect; 2021 Feb; 27(2):288.e1-288.e4. PubMed ID: 33198949
[TBL] [Abstract][Full Text] [Related]
32. Whole Genome Sequencing Results Associated with Minimum Inhibitory Concentrations of 14 Anti-Tuberculosis Drugs among Rifampicin-Resistant Isolates of
Kardan-Yamchi J; Kazemian H; Battaglia S; Abtahi H; Foroushani AR; Hamzelou G; Cirillo DM; Ghodousi A; Feizabadi MM
J Clin Med; 2020 Feb; 9(2):. PubMed ID: 32046149
[TBL] [Abstract][Full Text] [Related]
33. Proficiency testing for drug susceptibility testing of Mycobacterium tuberculosis complex using commercial broth microdilution plate in China in 2021.
Xia H; Song Y; Zheng Y; Zhou Y; Ou X; Wang S; Zhao B; Zhao Y
J Glob Antimicrob Resist; 2024 Mar; 36():230-236. PubMed ID: 38072239
[TBL] [Abstract][Full Text] [Related]
34. Prediction of drug resistance by Sanger sequencing of Mycobacterium tuberculosis complex strains isolated from multidrug resistant tuberculosis suspect patients in Ethiopia.
Mesfin EA; Merker M; Beyene D; Tesfaye A; Shuaib YA; Addise D; Tessema B; Niemann S
PLoS One; 2022; 17(8):e0271508. PubMed ID: 35930613
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.
Schön T; Juréen P; Giske CG; Chryssanthou E; Sturegård E; Werngren J; Kahlmeter G; Hoffner SE; Angeby KA
J Antimicrob Chemother; 2009 Oct; 64(4):786-93. PubMed ID: 19633001
[TBL] [Abstract][Full Text] [Related]
36. Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand.
Faksri K; Kaewprasert O; Ong RT; Suriyaphol P; Prammananan T; Teo YY; Srilohasin P; Chaiprasert A
Int J Antimicrob Agents; 2019 Aug; 54(2):109-116. PubMed ID: 30981926
[TBL] [Abstract][Full Text] [Related]
37. [Multicenter evaluation of broth microdilution test, BrothMIC MTB, to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for Mycobacterium tuberculosis--evaluation of interlaboratory precision and interpretive compatibility with agar proportion method].
Yamane N; Ichiyama S; Kawahara S; Iinuma Y; Saitoh H; Shimojima M; Udagawa H; Nakasone I
Rinsho Byori; 1999 Aug; 47(8):754-66. PubMed ID: 10511808
[TBL] [Abstract][Full Text] [Related]
38. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
Coban AY; Bilgin K; Uzun M; Durupinar B
Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of Mycobacterium tuberculosis cross-resistance to isoniazid, rifampicin and levofloxacin with their respective structural analogs.
Imperiale BR; Di Giulio ÁB; Adrián Cataldi A; Morcillo NS
J Antibiot (Tokyo); 2014 Nov; 67(11):749-54. PubMed ID: 24894185
[TBL] [Abstract][Full Text] [Related]
40. Estimation of country-specific tuberculosis resistance antibiograms using pathogen genomics and machine learning.
Dixit A; Freschi L; Vargas R; Gröschel MI; Nakhoul M; Tahseen S; Alam SMM; Kamal SMM; Skrahina A; Basilio RP; Lim DR; Ismail N; Farhat MR
BMJ Glob Health; 2024 Mar; 9(3):. PubMed ID: 38548342
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
